Patients with at least one copy of the HLA-A*31:01:02 allele may have an increased risk of developing DRESS as a result of taking oxcarbazepine as compared to patients who do not carry the HLA-A*31:01:02 allele. Other genetic and clinical factors may also affect a patient's risk of developing DRESS.